Ludwig Enterprises introduces Revealia™, a non-invasive cheek swab AI test for early cancer detection.

Ludwig Enterprises Inc. has introduced Revealia™, a non-invasive cheek swab test that uses artificial intelligence and machine learning for early cancer detection. The test analyzes mRNA-based genetic signals through the Revealia Inflammatory Index (RII), enabling quantification of cancer risk. With its continuously improving algorithms, Revealia™ aims to enhance accessibility and accuracy in cancer screening, potentially transforming public health.

September 24, 2024
19 Articles

Further Reading